Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biomerica Inc BMRA

Healthcare Medical Devices
Biomerica, Inc. is a biomedical technology company. The Company develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care (in home and in physicians’ offices) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. It is also engaged in the research, development, commercialization and in... see more

Recent & Breaking News (NDAQ:BMRA)

Biomerica Announces Closing of $8 Million Underwritten Public Offering of Common Stock

GlobeNewswire March 7, 2023

Biomerica Announces Pricing of $8 Million Underwritten Public Offering of Common Stock

GlobeNewswire March 3, 2023

Biomerica Announces Proposed Underwritten Public Offering of Common Stock

GlobeNewswire March 2, 2023

Barnwell Industries, Inc. Reaches Cooperation and Support Agreement With its Largest Stockholders

GlobeNewswire January 23, 2023

Biomerica Reports Financial Results for Fiscal 2023 Second Quarter Ended November 30, 2022

GlobeNewswire January 13, 2023

Biomerica Appoints Mayo Clinic Gastroenterologist, Dr. Brian E. Lacy, to the Company's Scientific Advisory Board

GlobeNewswire January 10, 2023

Biomerica Receives KFDA and Ministry of Health Approval for Colorectal Screening and Breast Screening Tests in Saudi Arabia and UAE

GlobeNewswire December 8, 2022

Biomerica InFoods® IBS Data Presented at the 2022 American College of Gastroenterology (ACG) Annual Scientific Meeting

GlobeNewswire November 2, 2022

Walmart to Expand Sales of Biomerica's Aware® Breast Self Exam; Product will now be available in over 2400 Walmart stores

GlobeNewswire October 14, 2022

Biomerica Reports 30% Increase in Revenues for Fiscal Q1 2023 vs. Fiscal Q1 2022

GlobeNewswire October 13, 2022

Biomerica's Aware® Breast Self Exam and EZ Detect(TM) Colon Disease Test Now Available on Amazon and Fulfilled by Amazon

GlobeNewswire September 29, 2022

Biomerica Plans Launch of InFoods® IBS Test; Names Robert Carlson as Chief Commercial Officer

GlobeNewswire August 30, 2022

Biomerica Reports Fiscal 2022 Year End Results

GlobeNewswire August 29, 2022

Walmart to Begin Selling Biomerica's Aware® Breast Self Exam

GlobeNewswire July 14, 2022

Biomerica to Participate at BTIG Biotech Conference

GlobeNewswire June 23, 2022

36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022

Accesswire May 16, 2022

Biomerica Announces CE Mark for Its H. pylori Diagnostic Test, hp+detect(TM)

GlobeNewswire May 12, 2022

Biomerica Announces FDA Submission For a Test to Detect Helicobacter pylori (H. pylori), a Bacteria That Infects Approximately 35% of the US Population

GlobeNewswire April 26, 2022

Biomerica Reports 111% Increase in Q3 Fiscal 2022 Revenues to $7.6 million vs. Q3 Fiscal 2021

GlobeNewswire April 14, 2022

Biomerica Announces Positive Topline Results from the Endpoint Clinical Trial of its InFoods® IBS Treatment for Patients with Irritable Bowel Syndrome

GlobeNewswire February 8, 2022